New Jersey is opening monkeypox vaccine eligibility to people considered at higher risk for the disease, even as vaccine supplies remain limited nationwide and local governments wait on shipments that are quickly outpaced by demand.
The JYNNEOS vaccine had already been available to New Jersey residents with known exposures to monkeypox, which is spread through skin-to-skin contact and can cause symptoms including lesions, swollen lymph nodes and rashes.
Three sites are now making the vaccine available to populations considered at-risk, by appointment only:
- Hyacinth AIDS Foundation/Project Living Out Loud!, Jersey City — 201-706-3480
- The Prevention Resource Network, Asbury Park — 732-502-5100
- North Jersey Community Research Initiative, Newark — 973-483-3444, ext. 200